Skip to Main Content

Paper Details

Engineering well-expressed, V2-immunofocusing HIV-1 envelope glycoprotein membrane trimers for use in heterologous prime-boost vaccine regimens.
PLoS Pathogens
7
2021
C-strand, D167N, Env, Env+, FP NAb, Gag, HIV, HIV-1, HIV-1 envelope glycoprotein membrane trimers, JR-FL trimers, N49, V1, V2, V2 MAb CH01, V2 apex, V3, V3 loops, disulfide, gp120, gp41, mannose
Author NameAffiliation
Bette KorberLos Alamos National Laboratory
Yaroslav TsybovskyFrederick National Laboratory for Cancer Research, Inc.
  • 1 - 2

Datasets